A CAR T Revolution: Allogene is Bringing Lifesaving Cancer Treatment to More Patients

CAR T therapy has delivered remarkable results for people with certain blood cancers—sometimes sending aggressive disease into deep remission after a single infusion. But today, only about 20% of eligible patients can actually get it.